Literature DB >> 22833355

CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.

Sanam Loghavi1, Ann E Walts, Shikha Bose.   

Abstract

ASC and LSIL comprise the majority of abnormal Pap smears. Currently, high-risk human papillomavirus testing is utilized to triage women with ASC for colposcopy; however, no cost effective triage method is available for LSIL. p16 and Ki-67 have each been shown to be good biomarkers for high grade cervical intraepithelial neoplasia (HG CIN).We evaluated the role of the CINtec® PLUS p16/Ki-67 dual immunostain as a marker for underlying (U) or subsequent (S) HG CIN. One hundred and eighty eight cervical SurePath Pap smears with histological and/or cytological follow-up were retrieved from our departmental files. The Pap stained slides were destained and then immunostained utilizing the CINtec® PLUS dual staining reagent kit. Results of the dual stain were correlated with follow-up diagnoses. Sensitivity, specificity, and positive and negative predictive values of CINtec® PLUS for U or S HG CIN were compared with those of HR HPV testing and with p16 and Ki-67 immunostaining alone. The sensitivity of CINtec® PLUS for U or S HG CIN was 91% in the ASC group and 100% in the LSIL group, while the corresponding specificities were 61 and 43%, respectively. The sensitivity and specificity of CINtec® PLUS for U or S HG CIN in both groups combined were 97 and 53%, respectively. CINtec® PLUS was more specific than HR HPV testing and Ki-67 and p16 immunostains alone in detecting an U or S HG CIN. CINtec® PLUS is a helpful adjunct in identifying U or S HG CIN when applied to SurePath Pap smears with ASC or LSIL.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833355     DOI: 10.1002/dc.22900

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  11 in total

Review 1.  [Indications for p16/Ki-67 in cervical cytology].

Authors:  P Ziemke; H Griesser
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

2.  Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.

Authors:  Carolina Areán-Cuns; Maria Mercado-Gutiérrez; Irene Paniello-Alastruey; Fermín Mallor-Giménez; Alicia Córdoba-Iturriagagoitia; Maria Lozano-Escario; Mercedes Santamaria-Martínez
Journal:  Virchows Arch       Date:  2018-08-09       Impact factor: 4.064

3.  The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3.

Authors:  Kristyn Manley; Amit Patel; Joya Pawade; Susan Glew; Katherine Hunt; Nichole Villeneuve; Pinias Mukonoweshuro; Samantha Thompson; Helen Hoskins; Andres López-Bernal; Andrew Wills
Journal:  Br J Cancer       Date:  2021-10-29       Impact factor: 7.640

4.  Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.

Authors:  Yi Qin; Ann E Walts; Beatrice S Knudsen; Arkadiusz Gertych
Journal:  Cytometry B Clin Cytom       Date:  2014-10-03       Impact factor: 3.058

Review 5.  Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.

Authors:  Cheng-Chieh Chen; Lee-Wen Huang; Chyi-Huey Bai; Chin-Cheng Lee
Journal:  Ann Saudi Med       Date:  2016 Jul-Aug       Impact factor: 1.526

6.  The Application of Classification and Regression Trees for the Triage of Women for Referral to Colposcopy and the Estimation of Risk for Cervical Intraepithelial Neoplasia: A Study Based on 1625 Cases with Incomplete Data from Molecular Tests.

Authors:  Abraham Pouliakis; Efrossyni Karakitsou; Charalampos Chrelias; Asimakis Pappas; Ioannis Panayiotides; George Valasoulis; Maria Kyrgiou; Evangelos Paraskevaidis; Petros Karakitsos
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

7.  The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.

Authors:  Júlio C Possati-Resende; José H T G Fregnani; Ligia M Kerr; Edmundo C Mauad; Adhemar Longatto-Filho; Cristovam Scapulatempo-Neto
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

8.  Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.

Authors:  M H Uijterwaal; B I Witte; F J Van Kemenade; D Rijkaart; R Ridder; J Berkhof; G A M A Balfoort-van der Meij; M C G Bleeker; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

9.  Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.

Authors:  Lu-Lu Yu; Wen Chen; Xiao-Qin Lei; Yu Qin; Ze-Ni Wu; Qin-Jing Pan; Xun Zhang; Bai-Feng Chang; Shao-Kai Zhang; Hui-Qin Guo; You-Lin Qiao
Journal:  Oncotarget       Date:  2016-04-19

10.  Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors.

Authors:  Diya Das; Moumita Sengupta; Keya Basu; Mona Tirkey; Chhanda Datta; Uttara Chatterjee
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.